drugset / Trial / NCT01509833

Efficacy of Low Dose hCG on Oocyte Maturity in Poor Responder Women Undergoing Intracytoplasmic Sperm Injection

NCT01509833

Phase 3 Completed 73 enrolled Royan Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a prospective, randomized, parallel, controlled trial to assess the efficacy of the late follicular phase administration of low dose hCG on oocyte maturity for ovarian stimulation in 73 poor respond patients undergoing intracytoplasmic sperm injection (ICSI) treatment.

Timeline

Start
2009-10
Primary completion
2011-03
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject hCG Unknown 100 iu
Subject hCG Unknown 200 iu
Background Recombinant human follicle stimulating hormone (r-hFSH) Protein / enzyme biologic 300 iu

Indications